Paul Mcbarron, E. VP, Fin, CFO and COO, Director at Cyclacel Pharmaceuticals, holds 70.10K shares in Cyclacel Pharmaceuticals (Ticker: CYCC). Most recently, Paul Mcbarron Bought $12,948 shares of Cyclacel Pharmaceuticals on May 22, 2013 for an estimated value of 39.17K.